Drug Profile
CT 112 - Nuo Therapeutics
Alternative Names: CT-112-Curative-Health-Services; Platelet-factor-4-peptide-CT-112Latest Information Update: 13 Apr 2016
Price :
$50
*
At a glance
- Originator Curative Health Services
- Developer Nuo Therapeutics
- Class Anti-inflammatories; Antirheumatics; Peptides
- Mechanism of Action Angiogenesis inhibitors; CXCR3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders; Inflammation
Most Recent Events
- 16 Nov 2014 No development reported - Preclinical for Autoimmune disorders in USA (PO)
- 16 Nov 2014 No development reported - Preclinical for Inflammation in USA (PO)
- 16 Nov 2014 No development reported - Preclinical for Inflammation in USA (Topical)